The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.
Descamps V, Helle F, Louandre C, Martin E, Brochot E, Izquierdo L, Fournier C, Hoffmann TW, Castelain S, Duverlie G, Galmiche A, François C.
Descamps V, et al. Among authors: brochot e.
Antiviral Res. 2015 Jun;118:93-102. doi: 10.1016/j.antiviral.2015.03.012. Epub 2015 Mar 28.
Antiviral Res. 2015.
PMID: 25823619